We observed constitutive cholesterol synthesis in multiple glioma tumor sphere lines harboring a variety of alterations in this pathway, including both EGFR and PDGFRA amplification and PTEN deletion, suggesting that cholesterol synthesis inhibition might be useful across a wide genomic spectrum. The gene discussed is PDGFRA; the disease is central nervous system cancer.